Home Drug Codes Q Codes Q5109 · IXIFI
Updated July 1st, 2026

IXIFI Q Code: Q5109

Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg

Login to unlock all benchmarks
Medicare Payment Limit ?
Not published
CMS publishes none for Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
No current ASP
Not available for Q3 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg
HCPCS Added Date January 1, 2019
Manufacturer Pfizer
Route of Administration Intravenous
Generic Status HCPCS Discontinued

About IXIFI

Ixifi is a medication aligned to the HCPCS Q Code: Q5109 for billing, pricing, and reimbursement purposes in the United States. It is an Immunology: Anti-TNF drug administered via the intravenous route and manufactured by Pfizer.

Manufacturers, reach out to us to add more information.

NDC Code Information

No NDC packages are aligned to Q5109 in publicly available CMS files.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
No public NDC alignments
Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

Biosimilar Information

IXIFI Approval Date: December 13, 2017

Product Name HCPCS Code Active Ingredient BLA Type
Remicade J1745 Infliximab 351(a) Originator Product
Inflectra Q5103 Infliximab 351(k) Biosimilar
Renflexis Q5104 Infliximab 351(k) Biosimilar
Ixifi Q5109 Infliximab 351(k) Biosimilar
Avsola Q5121 Infliximab 351(k) Biosimilar

IXIFI CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96413 Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415 Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)
Not on the CMS JW / JZ list

CMS does not include Ixifi (Q5109) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing Q5109. Wastage billing guide →

IXIFI Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Neovascular (Wet) Age-Related Macular Degeneration (AMD) Macular Edema Following Retinal Vein Occlusion (RVO) Diabetic Macular Edema (DME) Diabetic Retinopathy (DR) Retinopathy of Prematurity (ROP)

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available IXIFI billing and coding guide?
Our team has not identified a manufacturer-published source of billing and coding information for IXIFI. Please reach out to us if this is a mistake.
Are there any available IXIFI patient assistance programs?
Our team has not identified a source of patient assistance information for IXIFI. Please reach out to us if this is a mistake.
Where can I find IXIFI prescribing information?
IXIFI prescribing information can be found at the link below. Visit Here →
Where can I find IXIFI side effect information?
A link for IXIFI side effect information is not available.
Does billing IXIFI require JZ/JW wastage modifiers?
CMS does not include IXIFI (Q5109) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing Q5109. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.